Bacterial Vaginosis: Clinical Trials

20 trials for Bacterial Vaginosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 5 unknown, 1 recruiting, 1 terminated. 20 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 420Completed 13, Unknown 5, Recruiting 1, Terminated 1

Follow Bacterial Vaginosis: new trials by email Literature Review of Bacterial Vaginosis trials Research Report on Bacterial Vaginosis

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age
Longidaza, Metronidazole 500 mg - Bacterial Vaginosis
Phase 4UnknownI.M. Sechenov First Moscow State Medical University1002024-06-012025-04-09
A Pilot Study to Evaluate the Efficacy and Safety of Lactobacillus Species Suppositories on Vaginal Health and pH
Lactobacillus Species, Placebo - Bacterial Vaginosis
Phase 4UnknownVedic Lifesciences Pvt. Ltd.752022-01-032022-05-02
Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis
Dequalinium Chloride, Metronidazole Oral - Bacterial Vaginosis, Vaginal Infection
Phase 4TerminatedMedinova AG1512021-07-262024-10-16
A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis
Metronidazole vaginal suppositories, Metronidazole vaginal suppositories and Probiotics(Umeta-mimi) - Bacterial Vaginosis
Phase 4RecruitingPeking University Shenzhen Hospital1402020-02-012025-06-12
Evaluation of Efficacy and Safety of Gynomax® XL Ovule
Gynomax® XL Vaginal Ovule - Trichomonal Vaginitis, Bacterial Vaginosis
Phase 4CompletedExeltis Turkey1162019-04-032020-01-31
Probiotics as Adjuvant Treatment for Bacterial Vaginosis
"Probiotics" and "Metronidazole", Metronidazole Vaginal - Bacterial Vaginosis
Phase 4CompletedPeking University Shenzhen Hospital1262019-03-262021-07-09
The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis
Norethisterone enantate, Condoms - Bacterial Vaginosis, HIV
Phase 4CompletedLondon School of Hygiene and Tropical Medicine2502017-10-022020-03-12
Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis
Metronidazole Oral, "Metronidazole" and "Lactobacillus" - Bacterial Vaginosis, Recurrence
Phase 4CompletedPeking University Shenzhen Hospital662017-07-012021-02-01
The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis
Clindamycin palmitate hydrochloride dispersible tablet, Metronidazole Tablet - Bacterial Vaginosis
Phase 4UnknownGuangzhou Yipinhong Pharmaceutical CO.,LTD3002016-07-012017-03-15
Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity
NuvaRing - Bacterial Vaginosis, HIV
Phase 4CompletedUniversity of Washington1202016-05-012018-12-10
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
NuvaRing - Bacterial Vaginosis
Phase 4CompletedUniversity of Washington812016-03-012025-02-05
Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis
Vaginal lactic acid and glycogen gel, Metronidazole - Bacterial Vaginosis
Phase 4CompletedInsel Gruppe AG, University Hospital Bern322014-06-012022-04-08
Clindamycin to Reduce Preterm Birth in a Low Resource Setting
Clindamycin, Placebo - Pregnancy, Prematurity
Phase 4CompletedChristiana Care Health Services17262013-07-012016-07-18
Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis
N-Acetyl cysteine, Metronidazole + N-Acetyl cysteine, metronidazole - Bacterial Vaginosis
Phase 4UnknownMinia University902013-03-012013-04-26
Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy
Lactobacillus acidophilus, Placebo - Bacterial Vaginosis
Phase 4UnknownUniversità degli Studi di Brescia1002009-09-012012-03-20
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
Metronidazole - Bacterial Vaginosis
Phase 4CompletedUniversity of Pittsburgh122007-12-012017-05-11
Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis
Lactoserum (Dermacyd Femina®) - Bacterial Vaginosis
Phase 4CompletedSanofi1222007-09-012009-01-22
Treatment of Bacterial Vaginosis Combined With Human Lactobacilli
lactobacilli - Bacterial Vaginosis
Phase 4CompletedSkaraborg Hospital752007-01-012014-11-10
Treatment of Bacterial Vaginosis (BV) With Tinidazole
tinidazole, metronidazole - Bacterial Vaginosis
Phase 4CompletedUniversity of Alabama at Birmingham5932004-11-012017-12-02
Treatment of Bacterial Vaginosis
metronidazole and azithromycin - Bacterial Vaginosis
Phase 4CompletedUniversity of Alabama at Birmingham6002002-07-012017-03-01

Narrower conditions

Vaginosis, Bacterial (20)  ·  Recurrence (2)  ·  Bacterial Infections and Mycoses (1)  ·  Candidiasis, Vulvovaginal (1)  ·  Herpes Simplex (1)  ·  Premature Birth (1)  ·  Trichomonas Vaginitis (1)  ·  Vaginal Diseases (1)  ·  Vaginitis (1)

Broader conditions

Bacterial Infections (20)  ·  Female Urogenital Diseases (20)  ·  Female Urogenital Diseases and Pregnancy Complications (20)  ·  Genital Diseases (20)  ·  Genital Diseases, Female (20)  ·  Infections (20)  ·  Urogenital Diseases (20)  ·  Bacterial Infections and Mycoses (19)  ·  Vaginal Diseases (19)  ·  Vaginitis (19)  ·  Disease Attributes (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Candidiasis (1)  ·  DNA Virus Infections (1)

Interventions

Metronidazole (10)  ·  Lacteol (2)  ·  NuvaRing (2)  ·  Acetylcysteine (1)  ·  Azithromycin (1)  ·  Benchmarking (1)  ·  Clindamycin (1)  ·  Coconut Oil (1)  ·  Condoms (1)  ·  Dequalinium (1)  ·  Longidaza (1)  ·  Probiotics (1)  ·  Therapeutics (1)  ·  Tinidazole (1)  ·  clindamycin palmitate (1)

Sponsors

Peking University Shenzhen Hospital (3)  ·  University of Alabama at Birmingham (2)  ·  University of Washington (2)  ·  Christiana Care Health Services (1)  ·  Exeltis Turkey (1)  ·  Guangzhou Yipinhong Pharmaceutical CO.,LTD (1)  ·  I.M. Sechenov First Moscow State Medical University (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Medinova AG (1)  ·  Minia University (1)  ·  Sanofi (1)  ·  Skaraborg Hospital (1)  ·  University of Pittsburgh (1)  ·  Università degli Studi di Brescia (1)

Countries

China (4)  ·  United States (4)  ·  India (2)  ·  Brazil (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Italy (1)  ·  Kenya (1)  ·  Norway (1)  ·  Poland (1)  ·  Russia (1)  ·  Slovakia (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  Uganda (1)

Top investigators

Jane Schwebke, MD (2)  ·  Ruifang Wu, M.D. (2)  ·  Ahmed R El-Adawy, Professor (1)  ·  Andrea Lojacono, MD (1)  ·  Christine Johnston, MD, MPH (1)  ·  Heba A Mohamed, MSc (1)  ·  Jaderson Lima (1)  ·  Jeanne M Marrazzo, MD, MPH (1)  ·  Kseniya Rossolovskaya (1)  ·  Leonid Spivak, MD,Prof. (1)  ·  Long Sui, MD (1)  ·  Luana Danti, MD (1)  ·  Matthew K Hoffman, MD MPH (1)  ·  Petra Stute, MD (1)

Results publications

PMID 15028938, PMID 16303068, PMID 21854593, PMID 3485071, PMID 37575226, PMID 38336815, PMID 38696172, PMID 39762879, PMID 8244360

NIH funding

R01AI058033 (1), R01HD077872 (1), U19AI113173 (1)